The FDA granted approval Friday to Advanced Accelerator Applications for its drug Lutathera, which treats cancer that affects the pancreas or gastrointestinal tract. Here are four things to know. 1.
Vitamin D supplements have been shown to reduce the risk of relapse or death in patients with digestive tract cancer. Vitamin D supplements have been demonstrated to have a positive effect on some ...
In a comprehensive study, researchers from the Department of Epidemiology at the Faculty of Medicine at the University of Augsburg have provided reliable evidence for a link between chronic ...
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial) Authors retain all rights in any ...
Vitamin D supplementation significantly reduced the risk of relapse or death in a subgroup of patients with digestive tract cancer who were p53-immunoreactive, a recent analysis found. In the ...
Using data from over 1.5 million patients from 47 studies, the researchers analysed the association between four autoimmune diseases, most of which are acquired in childhood or younger adulthood, and ...
The researchers found positive associations for celiac disease, systemic lupus erythematosus, and type 1 diabetes with pancreatic, esophageal, colon, liver, and hepatobiliary cancers. HealthDay News — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results